Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

被引:1
|
作者
Ruiz-Irastorza, Guillermo [1 ]
Paredes-Ruiz, Diana [2 ]
Herrero-Galvan, Maria [3 ]
Moreno-Torres, Victor [4 ]
Hernandez-Negrin, Halbert [5 ,6 ]
Ruiz-Arruza, Ioana [1 ]
Leonard, Cedric [7 ]
Richez, Christophe [7 ]
Lazaro, Estibaliz [7 ]
机构
[1] Univ Basque Country, UPV EHU, Biobizkaia Hlth Res Inst, Bizkaia, Spain
[2] Biobizkaia Hlth Res Inst, Bizkaia, Spain
[3] Univ Basque Country, UPV EHU, Bizkaia, Spain
[4] Hosp Univ Cruces, Hosp Univ Puerta Hierro Majadahonda, UNIR Hlth Sci Sch, Madrid, Spain
[5] Hosp Univ Cruces, Hosp Reg Univ Malaga, Malaga, Spain
[6] Univ Malaga, Malaga, Spain
[7] Bordeaux Univ Hosp, Bordeaux, France
关键词
D O I
10.1002/acr.25334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The objective of this study was to analyze the effect of methylprednisolone pulses (MP), given during the first year after the diagnosis of systemic lupus erythematosus (SLE), in achieving prolonged remission according to the degree of lupus activity at presentation. Methods. We conducted an observational study of routine clinical care data from the Lupus-Cruces-Bordeaux cohort. The end point was prolonged remission (ie, during five consecutive yearly visits). The effect of MP on remission during the first year was analyzed in the whole cohort and according to the baseline Systemic Lupus Erythematosus Disease Activity Index 2000 score: <6, 6 to 12, and >12, reflecting mild, moderate, and severe activity, respectively. For adjustment, logistic regression with propensity score (PS) and other therapeutic covariates was performed. Results. Two hundred thirty-three patients were included. Prolonged remission was achieved by 132 patients (57%). MP were associated with prolonged remission (PS-adjusted odds ratio [OR] 2.50, 95% confidence interval [CI] 1.04-623, P = 0.042). A strong clinical effect was seen among patients with moderate (adjusted OR 5.28, 95% CI 1.27-21.97, P = 0.022) and moderate-severe SLE activity (adjusted OR 4.07, 95% CI 1.11-14.82, P = 0.033). The administration of MP resulted in reduced average dosages of prednisone during the first year among patient with moderate (mean 6.6 vs 10.2 mg/day, P = 0.017) and severe activity (mean 14 vs 28 mg/day, P = 0.015). The odds of prolonged remission were increased by longer-term use of hydroxychloroquine (HCQ) and decreased by higher initial doses of prednisone. Conclusion. This study supports the use of MP to induce prolonged remission in patients with SLE, particularly in those with moderate and severe activity. The extended use of HCQ also contributes to achieve prolonged remission. image
引用
收藏
页码:1132 / 1138
页数:7
相关论文
共 50 条
  • [41] Headache in Systemic Lupus Erythematosus Results From a Prospective, International Inception Cohort Study
    Hanly, John G.
    Urowitz, Murray B.
    O'Keeffe, Aidan G.
    Gordon, Caroline
    Bae, Sang-Cheol
    Sanchez-Guerrero, Jorge
    Romero-Diaz, Juanita
    Clarke, Ann E.
    Bernatsky, Sasha
    Wallace, Daniel J.
    Ginzler, Ellen M.
    Isenberg, David A.
    Rahman, Anisur
    Merrill, Joan T.
    Petri, Michelle
    Fortin, Paul R.
    Gladman, Dafna D.
    Fessler, Barri J.
    Alarcon, Graciela S.
    Bruce, Ian N.
    Dooley, Mary Anne
    Steinsson, Kristjan
    Khamashta, Munther A.
    Ramsey-Goldman, Rosalind
    Manzi, Susan
    Sturfelt, Gunnar K.
    Nived, Ola
    Zoma, Asad A.
    van Vollenhoven, Ronald F.
    Ramos-Casals, Manuel
    Aranow, Cynthia
    Mackay, Meggan
    Ruiz-Irastorza, Guillermo
    Kalunian, Kenneth C.
    Lim, S. Sam
    Inanc, Murat
    Kamen, Diane L.
    Peschken, Christine A.
    Jacobsen, Soren
    Theriault, Chris
    Thompson, Kara
    Farewell, Vernon
    ARTHRITIS AND RHEUMATISM, 2013, 65 (11): : 2887 - 2897
  • [42] Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study
    Hanly, John G.
    Su, Li
    Urowitz, Murray B.
    Romero-Diaz, Juanita
    Gordon, Caroline
    Bae, Sang-Cheol
    Bernatsky, Sasha
    Clarke, Ann E.
    Wallace, Daniel J.
    Merrill, Joan T.
    Isenberg, David A.
    Rahman, Anisur
    Ginzler, Ellen M.
    Petri, Michelle
    Bruce, Ian N.
    Dooley, M. A.
    Fortin, Paul
    Gladman, Dafna D.
    Sanchez-Guerrero, Jorge
    Steinsson, Kristjan
    Ramsey-Goldman, Rosalind
    Khamashta, Munther A.
    Aranow, Cynthia
    Alarcon, Graciela S.
    Fessler, Barri J.
    Manzi, Susan
    Nived, Ola
    Sturfelt, Gunnar K.
    Zoma, Asad A.
    van Vollenhoven, Ronald F.
    Ramos-Casals, Manuel
    Ruiz-Irastorza, Guillermo
    Lim, S. Sam
    Kalunian, Kenneth C.
    Inanc, Murat
    Kamen, Diane L.
    Peschken, Christine A.
    Jacobsen, Soren
    Askanase, Anca
    Theriault, Chris
    Thompson, Kara
    Farewell, Vernon
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) : 1837 - 1847
  • [43] Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus -: An international inception cohort study
    Hanly, J. G.
    Urowitz, M. B.
    Sanchez-Guerrero, J.
    Bae, S. C.
    Gordon, C.
    Wallace, D. J.
    Isenberg, D.
    Alarcon, G. S.
    Clarke, A.
    Bernatsky, S.
    Merrill, J. T.
    Petri, M.
    Dooley, M. A.
    Gladman, D.
    Fortin, P. R.
    Steinsson, K.
    Bruce, I.
    Manzi, S.
    Khamashta, M.
    Zoma, A.
    Aranow, C.
    Ginzler, E.
    Van Vollenhoven, R.
    Font, J.
    Sturfelt, G.
    Nived, O.
    Ramsey-Goldman, R.
    Kalunian, K.
    Douglas, J.
    Thompson, K.
    Farewell, V.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (01): : 265 - 273
  • [44] Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study
    Hanly, John G.
    Li, Qiuju
    Su, Li
    Urowitz, Murray B.
    Gordon, Caroline
    Bae, Sang-Cheol
    Romero-Diaz, Juanita
    Sanchez-Guerrero, Jorge
    Bernatsky, Sasha
    Clarke, Ann E.
    Wallace, Daniel J.
    Isenberg, David A.
    Rahman, Anisur
    Merrill, Joan T.
    Fortin, Paul
    Gladman, Dafna D.
    Bruce, Ian N.
    Petri, Michelle
    Ginzler, Ellen M.
    Dooley, M. A.
    Steinsson, Kristjan
    Ramsey-Goldman, Rosalind
    Zoma, Asad A.
    Manzi, Susan
    Nived, Ola
    Jonsen, Andreas
    Khamashta, Munther A.
    Alarcon, Graciela S.
    Chatham, Winn
    van Vollenhoven, Ronald F.
    Aranow, Cynthia
    Mackay, Meggan
    Ruiz-Irastorza, Guillermo
    Ramos-Casals, Manuel
    Lim, S. Sam
    Inanc, Murat
    Kalunian, Kenneth C.
    Jacobsen, Soren
    Peschken, Christine A.
    Kamen, Diane L.
    Askanase, Anca
    Theriault, Chris
    Farewell, Vernon
    ARTHRITIS CARE & RESEARCH, 2018, 70 (10) : 1478 - 1487
  • [45] Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort
    Saccon, Francesca
    Zen, Margherita
    Gatto, Mariele
    Margiotta, Domenico Paolo Emanuele
    Afeltra, Antonella
    Ceccarelli, Fulvia
    Conti, Fabrizio
    Bortoluzzi, Alessandra
    Govoni, Marcello
    Frontini, Giulia
    Moroni, Gabriella
    Dall'Ara, Francesca
    Tincani, Angela
    Signorini, Viola
    Mosca, Marta
    Frigo, Anna Chiara
    Iaccarino, Luca
    Doria, Andrea
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 943 - 950
  • [46] Remission and Low Disease Activity Are Associated with Lower Health Care Costs in an International Inception Cohort of Patients with Systemic Lupus Erythematosus
    Clarke, Ann E.
    Ugarte-Gil, Manuel
    Barber, Megan
    Hanly, John
    Urowitz, Murray
    Pierre, Yvan St.
    Gordon, Caroline
    Bae, Sang-Cheol
    Romero-Diaz, Juanita
    Sanchez-Guerrero, Jorge
    Bernatsky, Sasha
    Wallace, Daniel
    Isenberg, David
    Rahman, Anisur
    Merrill, Joan
    Fortin, Paul R.
    Gladman, Dafna
    Bruce, N.
    Petri, Michelle
    Ginzler, Ellen M.
    Dooley, Mary Anne
    Ramsey-Goldman, Rosalind
    Manzi, Susan
    Jonsen, Andreas
    Van Vollenhoven, Ronald
    Aranow, Cynthia
    Mackay, Meggan
    Ruiz-Irastorza, Guillermo
    Lim, S. Sam
    Inanc, Murat
    Kalunian, Kenneth
    Jacobsen, Soren
    Peschken, Christine
    Kamen, Diane
    Askanase, Anca
    Pons-Estel, Bernardo
    Alarcon, Graciela
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4121 - 4125
  • [47] Damage In Systemic Lupus Erythematosus Is a Potentially Modifiable Outcome: Results From The Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
    Bruce, Ian N.
    O'Keefe, Aidan
    Su, Li
    Farewell, Vernon
    Hanly, John G.
    Manzi, Susan
    Urowitz, Murray B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1242 - S1243
  • [49] Predictors of Persistent Disease Activity and Persistent Remission in Systemic Lupus Erythematosus - Results from the Hopkins Lupus Cohort
    Giannakou, Ioanna
    Chatzidionysiou, Katerina
    Gyori, Noemi
    Magder, Laurence S.
    van Vollenhoven, Ronald F.
    Petri, Michelle
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus
    Tsang-A-Sjoe, Michel W. P.
    Bultink, Irene E. M.
    Heslinga, Maaike
    Voskuyl, Alexandre E.
    RHEUMATOLOGY, 2017, 56 (01) : 121 - 128